Effects of treatment with growth hormone and somatostatin on efficacy of diammine [1,1-cyclobutane dicarboxylato (2-)-O,O']-(SP-4-2) in athymic rats with osteosarcoma

American Journal of Veterinary Research

Volumn 61, Issue 6, 2000, Pages 646-650

  Conzemius, Michael G ^a   Graham, Joanne C ^a   Haynes, Joseph S ^a   Graham, Christine A ^a,b  

^a IOWA STATE UNIVERSITY   (United States)

^b Animal Medical Referral Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA;

CARBOPLATIN; GROWTH HORMONE; SOMATOMEDIN B; SOMATOMEDIN C; SOMATOSTATIN; SP 4 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; FEMALE; LUNG METASTASIS; NONHUMAN; OSTEOSARCOMA; RAT;

EID: 0034038664     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2000.61.646     Document Type: Article

References (28)

1. Knox RJ, Friedlos F, Lydall DA, et al. Mechanism of cytotoxicily of anticancer platinum drugs: evidence that cis-diammine dichloroplatinum (II) and cis-diammine-(1,1-cyclobutane dicarboxylato) platinum (II) differ only in the kinetics of their interaction with DNA. Cancer Res 1986;46:1972-1979.
2. Thompson JP, Fugent MJ. Evaluation of survival times after limb amputation, with and without subsequent administration of cisplatin, for treatment of appendicular osleosarcoma in dogs: 30 cases (1979-1990). J Am Vet Med Assoc 1992;200:531-533.
3. Page RL, McEntee MC, George SL, et al. Pharmacokinetic and phase I evaluation of carboplatin in dogs. J Vet Intern Med 1993;7:235-240.
4. Pollak MN, Polychronakas C, Richard M. Insulin-like growth factor 1: a potent mitogen for human osteogenic sarcoma. J Nat Cancer Inst 1990;82:301-305.
5. Albertsson-Wilklan K, Rosberg S. Analyses of 24-hour growth hormone profiles in children: relation to growth. J Clin Endocrinol Metab 1988;67:493-500.
6. Lampi M, Velhuis JD, Johnson ML. Saltation and stasis: a model of human growth. Science 1992;258:801-803.
7. Conzemius MG, Smith GK, Brighton CT, et al. Analysis of physeal growth in dogs using biplanar radiography. Am J Vet Res 1994;55:22-27.
8. Conzemius MG, Chakraborty PK, Brown DC. Correlation between incremental growth, growth hormone and insulin-like growth factor 1 in the prepubertal dog. Am J Vet Res 1998;59:1608-1612.
9. Scheven BAA, Hamilton NJ. Longitudinal bone growth in vitro: effects of insulin-like growth factor and growth hormone. Acta Endocrinologica (Copenhagen) 1991;124:602-607.
10. Wit JM, Kamp GA, Rikken B. Spontaneous growth and response to growth hormone treatment in children with growth hormone deficiency and idiopathic short stature. Pediatr Res 1996;39:295-302.
11. Kappel CC, Velez-Yanguas MC, Hirschfeld S, et al. Human osteosarcoma cell lines are dependent on insulin-like growth factor 1 for in vitro growth. Cancer Res 1994;54:2803-2807.
12. Scheven BAA, Hamilton NJ, Fakkeldu TMV, et al. Effects of recombinant human insulin-like growth factor I and II and growth hormone on the growth of normal adult human osteoblast-like cells and human osteogenic sarcoma cells. Growth Regul 1991;1:160-167.
13. Barnard R, Ng KW, Martin TJ, et al. Growth hormone (GH) receptors in clonal osteoblast-like cells mediate a mitogenic response to GH. Endocrinology 1991;128:1459-1464.
14. Koutsilieris M, Reyes-Moreno C, Sourla A, et al. Growth factors mediate glucocorticoid receptor function and dexamethasone-induced regression of osteoblastic lesions in hormone refractory prostate cancer. Anticancer Res 1997;17:1461-1465.
15. Pinski J, Schally AV, Halmos G, et al. Somatostatin analog RC-160 inhibits the growth of human osteosarcoma in nude mice. Int J Cancer 1996;65:870-874.
16. Slootweg MC, Ohlsson C, Salles JP, et al. Insulin-like growth factor binding proteins-2 and -3 stimulate growth hormone receptor binding and mitogenesis in rat osteosarcoma cells. Endocrinology 1995;136:4210-4217.
17. Partridge NC, Alcorn D, Micheliangli VP, et al. Morphological and biochemical characterization of four clonal osteogenic sarcoma cell lines of rat origin. Cancer Res 1983;43:4308-4315.
18. Martin TJ, Ng KW, Partridge NC, et al. Hormonal influences on bone cells. Methods Enzymol 1987;145:324-336.
19. Leibbrandt ME, Wolfgang GH. Differential toxicity of cisplatin, carboplatin, and CI-973 correlates with cellular platinum levels in rat renal cortical slices. J Phann Sci 1995;84:1442-1445.
20. Lindner PG, Heath D, Howell SB, et al. Digitonin enhances the efficacy of carboplatin in liver tumour after intra-arterial administration. Cancer Chemother Pharmacol 1997;40:444-448.
21. Los G, Nagel JD, McVie JG. Anti-tumor effect of cisplatin, carboplatin, mitoxantrone, and doxorubicin on peritoneal tumor growth after intraperitoneal and intravenous chemotherapy: a comparative study. Sel Cancer Ther 1990;6:73-82.
22. Los G, Smals OA, van Vugt MJ, et al. A rationale for carboplatin treatment and abdominal hyperthermia in cancers restricted to the peritoneal cavity. Cancer Res 1992;52:1252-1258.
23. Pinski J, Schally AV, Halmos G, et al. Somatostatin analog RC-160 inhibits the growth of human osteosarcomas in nude mice. Int J Cancer 1996;65:870-874.
24. Wolf RF, Ng B, Weksler, et al. Effect of growth hormone on tumor and host in an animal model. Ann Surg Oncol 1994;4:314-320.
25. Redding TW, Schally AV. Inhibition of growth of transplantable rat osteosarcoma by analogs of hypothalamic hormones. Proc Nat Acad Sci U S A 1983;80:1078-1082.
26. Witzel JG, Prescher A. An experimental osteosarcoma of the athymic nude rat. Invasion Metastasis 1991;11:110-115.
27. Brooks CG. Studies on the immunobiology of rnu/rnu. "Nude" rats with congenital aplasia of the thymus. Eur J Immunol 1980;10:58-65.
28. Kjonniksen I, Winderen M, Bruland O, et al. Validity and usefulness of human tumor models established by intratibial cell inoculation in nude rats. Cancer Res 1994;54:1715-1719.